3SBio Receives $337 Million Go-Private Offer

3SBio, a China biotech, received an offer to take the company private at a price of $15 per share, a transaction that values the company at $337 million. The offer was made by Dr. Jing Lou, 3SBio’s Chairman and CEO, along with CPEChina Fund LP, a Cayman Island entity associated with CITIC Private Equity Fund. The offer was priced at a 32% premium to yesterday’s closing price of $11.39. In today’s trading, 3SBio rose $1.84 to $13.43, a 16% increase. Even at the buyout price, 3SBio has a lot of value. More details.... Stock Symbol: (NSDQ: SSRX) Share this with colleagues: var switchTo5x=true; stLight.options({publisher:'d7871f5b-67bc-4d30-b66f-1465d0b97213'});